deltatrials
Unknown NA INTERVENTIONAL 4-arm NCT00565396

Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3 (FLIP)

Multi-Center,Double-Blind,Randomized,Controlled Clinical Trial of Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3

Sponsor: Shanghai Municipal Health Bureau

Conditions Angiotensin II Type 1 Receptor Blockers Angiotensin-Converting Enzyme Inhibitors Chronic Kidney Insufficiency Proteinuria
Interventions Fosinopril and Losartan
Updated 5 times since 2017 Last updated: Nov 29, 2007 Started: Sep 30, 2004 Completion: Jul 31, 2008
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Angiotensin II Type 1 Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors, this trial is ongoing. The trial is conducted by Shanghai Municipal Health Bureau and has accumulated 5 data snapshots since 2004. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 24 months · monthly snapshotUnknown

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown NA

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown NA

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status NA

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status NA

  5. Jan 2017 — Jun 2018 [monthly]

    Unknown Status NA

    First recorded

Sep 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Shanghai Municipal Health Bureau
Data source: Shanghai Municipal Health Bureau

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations